Attached files

file filename
EX-3.2 - FORM OF AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION - COVA Acquisition Corp.fs12021a2ex3-2_covaacq.htm
S-1/A - REGISTRATION STATEMENT - COVA Acquisition Corp.fs12021a2_covaacq.htm
EX-99.4 - CONSENT OF JACK SMITH TO BE NAMED AS A DIRECTOR NOMINEE - COVA Acquisition Corp.fs12021a2ex99-4_covaacq.htm
EX-99.3 - CONSENT OF PANDU SJAHRIR TO BE NAMED AS A DIRECTOR NOMINEE - COVA Acquisition Corp.fs12021a2ex99-3_covaacq.htm
EX-99.2 - CONSENT OF ALVIN W. SARIAATMADJA TO BE NAMED AS A DIRECTOR NOMINEE - COVA Acquisition Corp.fs12021a2ex99-2_covaacq.htm
EX-99.1 - CONSENT OF KARANVEER DHILLON TO BE NAMED AS A DIRECTOR NOMINEE - COVA Acquisition Corp.fs12021a2ex99-1_covaacq.htm
EX-23.1 - CONSENT OF WITHUMSMITH+BROWN, PC. - COVA Acquisition Corp.fs12021a2ex23-1_covaacq.htm
EX-10.8 - FORM OF LETTER AGREEMENT BETWEEN THE REGISTRANT, THE SPONSOR AND EACH DIRECTOR A - COVA Acquisition Corp.fs12021a2ex10-8_covaacq.htm
EX-10.9 - FORM OF ADMINISTRATIVE SERVICES AGREEMENT BETWEEN THE REGISTRANT AND THE SPONSOR - COVA Acquisition Corp.fs12021a2ex10-9_covaacq.htm
EX-10.5 - FORM OF ADMINISTRATIVE SERVICES AGREEMENT BETWEEN THE REGISTRANT AND THE SPONSOR - COVA Acquisition Corp.fs12021a2ex10-5_covaacq.htm
EX-10.4 - FORM OF INDEMNITY AGREEMENT - COVA Acquisition Corp.fs12021a2ex10-4_covaacq.htm
EX-10.3 - FORM OF PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT BETWEEN THE REGISTRANT AND - COVA Acquisition Corp.fs12021a2ex10-3_covaacq.htm
EX-10.2 - FORM OF REGISTRATION AND SHAREHOLDER RIGHTS AGREEMENT AMONG THE REGISTRANT, THE - COVA Acquisition Corp.fs12021a2ex10-2_covaacq.htm
EX-10.1 - FORM OF INVESTMENT MANAGEMENT TRUST AGREEMENT BETWEEN CONTINENTAL STOCK TRANSFER - COVA Acquisition Corp.fs12021a2ex10-1_covaacq.htm
EX-5.2 - OPINION OF MAPLES AND CALDER, CAYMAN ISLANDS COUNSEL TO THE REGISTRANT - COVA Acquisition Corp.fs12021a2ex5-2_covaacq.htm
EX-4.4 - FORM OF WARRANT AGREEMENT BETWEEN CONTINENTAL STOCK TRANSFER & TRUST COMPANY AND - COVA Acquisition Corp.fs12021a2ex4-4_covaacq.htm
EX-4.3 - SPECIMEN WARRANT CERTIFICATE - COVA Acquisition Corp.fs12021a2ex4-3_covaacq.htm
EX-4.2 - SPECIMEN CLASS A ORDINARY SHARE CERTIFICATE - COVA Acquisition Corp.fs12021a2ex4-2_covaacq.htm
EX-4.1 - SPECIMEN UNIT CERTIFICATE - COVA Acquisition Corp.fs12021a2ex4-1_covaacq.htm
EX-3.1 - INTERIM AMENDED MEMORANDUM AND ARTICLES OF ASSOCIATION - COVA Acquisition Corp.fs12021a2ex3-1_covaacq.htm
EX-1.1 - FORM OF UNDERWRITING AGREEMENT - COVA Acquisition Corp.fs12021a2ex1-1_covaacq.htm

Exhibit 5.1

 

 
   
 

Orrick, Herrington & Sutcliffe LLP

222 Berkeley Street, Suite 2000
Boston, MA 02116

+1 617 880-1800

orrick.com

 

January 29, 2021

 

COVA Acquisition Corp.

530 Bush Street, Suite 703

San Francisco, CA 94108

 

Re:Registration Statement on Form S-1

 

Ladies and Gentlemen:

 

We are acting as counsel to COVA Acquisition Corp., a Cayman Islands exempted company (the “Company”), in connection with the registration statement on Form S-1 filed by the Company with the Securities and Exchange Commission (the “Commission”) on January 22, 2021, as amended by Amendment No. 1 filed with the Commission on January 27, 2021 and Amendment No. 2 filed with the Commission on January 29, 2021 (the “Registration Statement”), under the Securities Act of 1933, as amended (the “Securities Act”). The Registration Statement relates to the registration of 28,750,000 units, including 3,750,000 units that may be sold pursuant to the underwriters’ over-allotment option (collectively, the “Units”), with each Unit consisting of (a) one Class A ordinary share, par value $0.0001 per share (“Class A Ordinary Shares”), of the Company and (b) one-half of one redeemable warrant of the Company (each, a “Warrant”), with one whole Warrant entitling the holder thereof to purchase one Class A Ordinary Share for an aggregate of 12,500,000 Warrants or up to 14,375,000 Warrants upon exercise of the underwriters’ over-allotment option. The Units will be offered and sold as described in the Registration Statement and pursuant to an underwriting agreement substantially in the form filed as an exhibit to the Registration Statement, to be entered into by and among the Company and representatives of the underwriters named therein (the “Underwriting Agreement”).

 

In connection with rendering the opinions set forth below, we have examined and relied upon originals or copies, certified or otherwise identified to our satisfaction, of instruments, documents and records which we deemed relevant and necessary for the purpose of rendering our opinion set forth below. In such examination, we have assumed the following: (a) the authenticity of original documents and the genuineness of all signatures, (b) the conformity to the originals of all documents submitted to us as copies, (c) the legal capacity of natural persons, and (d) the representations of officers and employees are correct as to questions of fact.

 

 

 

 

COVA Acquisition Corp.

January 29, 2021
Page 2

 

We have also assumed that that at or prior to the time of the delivery of any Units, (i) the Board of Directors of the Company shall have duly established the terms of the Units and the Shares and the Warrants included therein and duly authorized the issuance and sale of the Units and such authorization shall not have been modified or rescinded; (ii) the Company is, and shall remain, validly existing as a corporation under the laws of the Cayman Islands and has the corporate power and authority to execute, deliver and perform all its obligations under the Units and the Warrant Agreement proposed to be entered into by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent (the “Warrant Agreement”), filed as Exhibit 4.4 to the Registration Statement; (iii) the Registration Statement shall have been declared effective and such effectiveness shall not have been terminated or rescinded; (iv) the Warrant Agreement has been duly authorized, executed and delivered by the Warrant Agent and the Company, and is a valid, binding and enforceable agreement of each party thereto; (v) neither the execution and delivery by the Company of the Warrant Agreement nor the performance by the Company of its obligations thereunder, including the issuance and sale of the Units: (A) conflicts with or will conflict with the Memorandum of Articles of Association of the Company or the Amended and Restated Memorandum and Articles of Association of the Company; (B) constitutes or will constitute a violation of, or a default under, any lease, indenture, instrument or other agreement to which the Company or its property is subject; (C) contravenes or will contravene any order or decree of any governmental authority to which the Company or its property is subject; or (D) violates or will violate any law, rule or regulation to which the Company or its property is subject (except that we do not make the assumption set forth in this clause (D) with respect to the laws of the State of New York); and (vi) neither the execution and delivery by the Company of the Warrant Agreement nor the performance by the Company of its obligations thereunder, including the issuance and sale of the Units, requires or will require the consent, approval, licensing or authorization of, or any filing, recording or registration with, any governmental authority under any law, rule or regulation of any jurisdiction.

 

Our opinion herein is limited to the laws of the State of New York.

 

Based upon the foregoing, we are of the opinion that:

 

1. The Units, when delivered and paid for pursuant to the Underwriting Agreement, will constitute valid and binding obligations of the Company, enforceable against the Company in accordance with their terms.

 

2. The Warrants, when delivered and paid for pursuant to the Underwriting Agreement, will constitute valid and binding obligations of the Company, enforceable against the Company in accordance with their terms.

 

Our opinion set forth above is subject to (i) the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other similar laws relating to or affecting creditors’ rights generally, (ii) general equitable principles (whether considered in a proceeding in equity or at law), and (iii) an implied covenant of good faith and fair dealing.

 

We consent to the filing of this opinion as an exhibit to the Registration Statement, and we further consent to the use of our name under the caption “Legal Matters” in the Registration Statement and the prospectus that forms a part thereof. In giving these consents, we do not thereby admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission promulgated thereunder, nor do we thereby admit that we are “experts” within the meaning of such term as used in the Securities Act with respect to any part of the Registration Statement, including this opinion letter as an exhibit or otherwise.

 

Very truly yours,

 

/s/ Orrick, Herrington & Sutcliffe LLP

 

ORRICK, HERRINGTON & SUTCLIFFE LLP